For more than six decades, metformin has served as the cornerstone of pharmacological management for type 2 diabetes. Since its…
Read More
CMS Seeks Lab Input on Sweeping Anti-Fraud Rules Targeting Genetic Testing Overspending
With genetic test spending under the microscope, CMS is asking labs to help shape future anti-fraud rules—before formal proposals are…
Read More
With genetic test spending under the microscope, CMS is asking labs to help shape future anti-fraud rules—before formal proposals are drafted.
The Centers for Medicare and Medicaid Services (CMS) has initiated a critical dialogue with the clinical laboratory community, seeking direct…
Read More
Breakthrough Research Reveals the Brain as a Primary Driver of Metformin’s Anti-Diabetic Effects through Rap1 Signaling
For more than six decades, metformin has served as the foundational pharmacotherapy for the management of type 2 diabetes, a…
Read More
Novartis to Acquire Excellergy for Up to $2 Billion to Bolster Next-Generation Anti-IgE Allergy Pipeline
Novartis has entered into a definitive agreement to acquire Excellergy, a privately held biotechnology company specializing in the development of…
Read More
CMS Launches Sweeping Anti-Fraud Initiative, Targeting Genetic Testing Spending and Soliciting Lab Industry Input for Future Regulations
The Centers for Medicare and Medicaid Services (CMS) has embarked on a significant preemptive strike against healthcare fraud, initiating a…
Read More
TWiV 1290: Clinical Update with Dr. Daniel Griffin Discusses Screwworm, Shingles Vaccine’s Anti-Aging Effects, and Current Public Health Data
In a recent clinical update featured on "This Week in Virology" (TWiV) episode 1290, Dr. Daniel Griffin provided a comprehensive…
Read More
Glioblastoma Immune Cells Hijack Fructose Metabolism to Suppress Anti-Tumor Responses, Unveiling a Novel Therapeutic Pathway.
In a significant breakthrough that could reshape the therapeutic landscape for one of the most aggressive and intractable brain cancers,…
Read More
With genetic test spending under the microscope, CMS is asking labs to help shape future anti-fraud rules—before formal proposals are drafted.
Clinical laboratory leaders faced a critical, albeit narrowing, window to influence a significant new federal anti-fraud initiative launched by the…
Read More
